Patient flow is the path a patient takes from first symptoms to ongoing treatment. It sounds like a clinical topic. In practice it is one of the most commercial pieces of analysis an Access team can do, because it shows where patients are, who decides for them, and who pays.
Start with one patient
Pick a typical patient and ask a sequence of plain questions.
- Where do they first present: primary care, emergency, a specialist clinic?
- Who makes the diagnosis, and how long does it take?
- Where are they treated: a public hospital, a military or university hospital, a private provider?
- Who funds their care in that setting: a ministry budget, an insurer, the patient?
- What is on that institution's formulary today, and who decides what is added?
In MENA, the answers can differ sharply between a citizen and an expatriate, or between government and private sectors in the same city. That is exactly why the exercise matters.
What it changes
- Your stakeholder map. The people who matter are the ones on the patient's path, not the ones with the biggest titles.
- Your budget model. Eligible patients are only those who reach a prescriber in a setting where the medicine can be funded.
- Your priorities. If most patients are treated in a handful of centers, access there is worth more than broad national activity.
- Your solutions. If patients are lost before diagnosis, the barrier is not reimbursement. It may be awareness, referral or testing.
Make it visual
The most useful patient flow analysis fits on one page: the steps, the numbers at each step, and the drop-off between them. It becomes a shared reference for medical, marketing and Access colleagues, and it often settles arguments about where to invest before they start.